Chase Investment Counsel’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,596
| Closed | -$3.2M | – | 151 |
|
|
2025
Q1 | $3.2M | Sell |
6,596
-372
| -5% | -$180K | 1.17% | 36 |
|
|
2024
Q4 | $2.81M | Sell |
6,968
-95
| -1% | -$38.3K | 0.9% | 37 |
|
|
2024
Q3 | $3.28M | Sell |
7,063
-1,185
| -14% | -$551K | 1.09% | 40 |
|
|
2024
Q2 | $3.87M | Buy |
8,248
+145
| +2% | +$68K | 1.37% | 24 |
|
|
2024
Q1 | $3.39M | Buy |
8,103
+1,359
| +20% | +$568K | 1.26% | 29 |
|
|
2023
Q4 | $2.74M | Sell |
6,744
-436
| -6% | -$177K | 1.21% | 28 |
|
|
2023
Q3 | $2.5M | Buy |
7,180
+55
| +0.8% | +$19.1K | 1.25% | 32 |
|
|
2023
Q2 | $2.51M | Buy |
7,125
+144
| +2% | +$50.7K | 1.26% | 32 |
|
|
2023
Q1 | $2.2M | Buy |
6,981
+80
| +1% | +$25.2K | 1.22% | 32 |
|
|
2022
Q4 | $1.99M | Sell |
6,901
-4,535
| -40% | -$1.31M | 1.22% | 37 |
|
|
2022
Q3 | $3.31M | Buy |
11,436
+3,034
| +36% | +$878K | 2.09% | 16 |
|
|
2022
Q2 | $2.37M | Buy |
+8,402
| New | +$2.37M | 1.28% | 33 |
|
|
2020
Q4 | – | Sell |
-11,375
| Closed | -$3.1M | – | 109 |
|
|
2020
Q3 | $3.1M | Sell |
11,375
-1,886
| -14% | -$513K | 1.54% | 22 |
|
|
2020
Q2 | $3.85M | Sell |
13,261
-3,022
| -19% | -$877K | 1.95% | 12 |
|
|
2020
Q1 | $3.87M | Buy |
+16,283
| New | +$3.87M | 2.61% | 12 |
|